今日盘中，泰格医药（03347）股价大涨8.91%，引发市场广泛关注。截至发稿，该股报46.44港元，成交额2136.07万港元。
消息面上，泰格医药近日发布了2025年第三季度财报，业绩表现亮眼。公司前三季度实现营业收入50.26亿元，同比略降0.82%；归属于母公司股东的净利润10.2亿元，同比增长25.45%。尤其值得注意的是，单看第三季度数据，公司实现营业收入17.75亿元，同比增长3.86%；归属于母公司股东的净利润达6.37亿元，同比大幅增长98.73%。
分析人士认为，泰格医药第三季度净利润的显著增长是推动股价上涨的主要原因。这一业绩改善显示公司盈利能力持续增强，有效提振了投资者信心。此外，公司在临床试验服务领域的领先地位，以及全球化布局策略，也可能是支撑股价上涨的长期因素。投资者应密切关注公司后续经营状况和行业发展趋势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.